171 related articles for article (PubMed ID: 17949716)
1. Ataxin-2 mediated cell death is dependent on domains downstream of the polyQ repeat.
Ng H; Pulst SM; Huynh DP
Exp Neurol; 2007 Dec; 208(2):207-15. PubMed ID: 17949716
[TBL] [Abstract][Full Text] [Related]
2. Expansion of the polyQ repeat in ataxin-2 alters its Golgi localization, disrupts the Golgi complex and causes cell death.
Huynh DP; Yang HT; Vakharia H; Nguyen D; Pulst SM
Hum Mol Genet; 2003 Jul; 12(13):1485-96. PubMed ID: 12812977
[TBL] [Abstract][Full Text] [Related]
3. Ataxin-2 interacts with FUS and intermediate-length polyglutamine expansions enhance FUS-related pathology in amyotrophic lateral sclerosis.
Farg MA; Soo KY; Warraich ST; Sundaramoorthy V; Blair IP; Atkin JD
Hum Mol Genet; 2013 Feb; 22(4):717-28. PubMed ID: 23172909
[TBL] [Abstract][Full Text] [Related]
4. Parkin is an E3 ubiquitin-ligase for normal and mutant ataxin-2 and prevents ataxin-2-induced cell death.
Huynh DP; Nguyen DT; Pulst-Korenberg JB; Brice A; Pulst SM
Exp Neurol; 2007 Feb; 203(2):531-41. PubMed ID: 17097639
[TBL] [Abstract][Full Text] [Related]
5. Amino acid sequences flanking polyglutamine stretches influence their potential for aggregate formation.
Nozaki K; Onodera O; Takano H; Tsuji S
Neuroreport; 2001 Oct; 12(15):3357-64. PubMed ID: 11711886
[TBL] [Abstract][Full Text] [Related]
6. Identification of human proteins that modify misfolding and proteotoxicity of pathogenic ataxin-1.
Petrakis S; Raskó T; Russ J; Friedrich RP; Stroedicke M; Riechers SP; Muehlenberg K; Möller A; Reinhardt A; Vinayagam A; Schaefer MH; Boutros M; Tricoire H; Andrade-Navarro MA; Wanker EE
PLoS Genet; 2012; 8(8):e1002897. PubMed ID: 22916034
[TBL] [Abstract][Full Text] [Related]
7. ALS-associated ataxin 2 polyQ expansions enhance stress-induced caspase 3 activation and increase TDP-43 pathological modifications.
Hart MP; Gitler AD
J Neurosci; 2012 Jul; 32(27):9133-42. PubMed ID: 22764223
[TBL] [Abstract][Full Text] [Related]
8. Proteolytic cleavage of ataxin-7 by caspase-7 modulates cellular toxicity and transcriptional dysregulation.
Young JE; Gouw L; Propp S; Sopher BL; Taylor J; Lin A; Hermel E; Logvinova A; Chen SF; Chen S; Bredesen DE; Truant R; Ptacek LJ; La Spada AR; Ellerby LM
J Biol Chem; 2007 Oct; 282(41):30150-60. PubMed ID: 17646170
[TBL] [Abstract][Full Text] [Related]
9. Progress in pathogenesis studies of spinocerebellar ataxia type 1.
Cummings CJ; Orr HT; Zoghbi HY
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1079-81. PubMed ID: 10434309
[TBL] [Abstract][Full Text] [Related]
10. Toxicity of pathogenic ataxin-2 in Drosophila shows dependence on a pure CAG repeat sequence.
McGurk L; Rifai OM; Shcherbakova O; Perlegos AE; Byrns CN; Carranza FR; Zhou HW; Kim HJ; Zhu Y; Bonini NM
Hum Mol Genet; 2021 Sep; 30(19):1797-1810. PubMed ID: 34077532
[TBL] [Abstract][Full Text] [Related]
11. Co-chaperone CHIP promotes aggregation of ataxin-1.
Choi JY; Ryu JH; Kim HS; Park SG; Bae KH; Kang S; Myung PK; Cho S; Park BC; Lee DH
Mol Cell Neurosci; 2007 Jan; 34(1):69-79. PubMed ID: 17127076
[TBL] [Abstract][Full Text] [Related]
12. Molecular pathogenesis and cellular pathology of spinocerebellar ataxia type 7 neurodegeneration.
Garden GA; La Spada AR
Cerebellum; 2008; 7(2):138-49. PubMed ID: 18418675
[TBL] [Abstract][Full Text] [Related]
13. The role of protein composition in specifying nuclear inclusion formation in polyglutamine disease.
Chai Y; Wu L; Griffin JD; Paulson HL
J Biol Chem; 2001 Nov; 276(48):44889-97. PubMed ID: 11572863
[TBL] [Abstract][Full Text] [Related]
14. RNA toxicity is a component of ataxin-3 degeneration in Drosophila.
Li LB; Yu Z; Teng X; Bonini NM
Nature; 2008 Jun; 453(7198):1107-11. PubMed ID: 18449188
[TBL] [Abstract][Full Text] [Related]
15. Ataxin-1 fusion partners alter polyQ lethality and aggregation.
Rich T; Varadaraj A
PLoS One; 2007 Oct; 2(10):e1014. PubMed ID: 17925862
[TBL] [Abstract][Full Text] [Related]
16. Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: removal of the CAG containing exon.
Evers MM; Tran HD; Zalachoras I; Pepers BA; Meijer OC; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; van Roon-Mom WM
Neurobiol Dis; 2013 Oct; 58():49-56. PubMed ID: 23659897
[TBL] [Abstract][Full Text] [Related]
17. Insights into the evolution and domain structure of Ataxin-2 proteins across eukaryotes.
Jiménez-López D; Guzmán P
BMC Res Notes; 2014 Jul; 7():453. PubMed ID: 25027299
[TBL] [Abstract][Full Text] [Related]
18. Polyglutamine expansion accelerates the dynamics of ataxin-1 and does not result in aggregate formation.
Krol HA; Krawczyk PM; Bosch KS; Aten JA; Hol EM; Reits EA
PLoS One; 2008 Jan; 3(1):e1503. PubMed ID: 18231590
[TBL] [Abstract][Full Text] [Related]
19. Cyclin-dependent kinase 5 phosphorylates and induces the degradation of ataxin-2.
Asada A; Yamazaki R; Kino Y; Saito T; Kimura T; Miyake M; Hasegawa M; Nukina N; Hisanaga S
Neurosci Lett; 2014 Mar; 563():112-7. PubMed ID: 24486837
[TBL] [Abstract][Full Text] [Related]
20. Polyglutamine tracts regulate beclin 1-dependent autophagy.
Ashkenazi A; Bento CF; Ricketts T; Vicinanza M; Siddiqi F; Pavel M; Squitieri F; Hardenberg MC; Imarisio S; Menzies FM; Rubinsztein DC
Nature; 2017 May; 545(7652):108-111. PubMed ID: 28445460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
